Синтез модифицированных аналогов стероидных эстрогенов
Диссертация
Создание моделей гормон-рецепторного связывания должно помочь в отборе соединений с избирательным биологическим действием, лишенных гормональных эффектов. Предложено несколько таких моделей, наиболее известная принадлежит Катценелленбогену с соавторами. Она имеет ряд ограничений, например, не описывает эффекты 8-изоаналогов стероидных эстрогенов. Это является существенным недостатком, поскольку… Читать ещё >
Список литературы
- Tsai M.-J., and Malley Bert W.O. Molecular mechanisme of steroid/thyroid receptor superfamily members. // Annu. Rev. Biochem. — 1994. — V. 63.- P. 451 486.
- Hardy S.P. and Valverde M.A. Novel plasma membrane action of estrogen and antiestrogens revealed by their regulation of a large conductance chloride channel. // FASEB J. 1994. — V. 8. — P. 760−765.
- Evans R.M. The Steroid and Thyroid Hormone Receptor Superfamily. // Science. 1988. — V. 240. — P. 889−895.
- Pakdel F., Le Gac F., Le Goff P., Valotaire Y. Full-length sequence and in vitro expression of rainbow trout estrogen receptor cDNA. // Mol. Cell. Endocrinol. 1990. — V. 71. — P. 195−204.
- Koike S., Sakai M., Muramatsu M. Molecular cloning and characterization of rat estrogen receptor cDNA. // Nucleic Acids Res. 1987. — V. 15. — P. 24 992 513.
- White R., Lees J.A., Needham M., Ham J., Parker M. Structural organization and expression of the mouse estrogen receptor. // Mol. Endocrinol. 1987. — V. 1. -P. 735−744.
- Green S., Walter P., Kumar V., Krust A., Bomert J.M., Argos P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. // Nature. 1986. — V. 320. — P. 134−139.
- Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. // Science. -1986.-V. 231.-P. 1150−1154.
- Bokenkamp D., Jungblut P.W., Thole H.H. The C-terminal half of the porcine estradiol receptor contains no post-translational modification: determination of the primary structure. // Mol. Cell. Endocrinol. 1994. — V. 104. — P. 163−172.
- Godowski P. J, Picard D, Yamamoto K.R. Signal Transduction and Transcriptional Regulation by Glucocorticoid Receptor-LexA Fusion Proteins. //
- Science. 1988. — V. 241 — P. 812−816.
- Luisi B. F, Xu W. X, Otwinowski Z, Freedman L. P, Yamomoto K.R. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. //Nature. 1991. — V. 352. — P. 497−505.
- Kuiper G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. // Proc. Natl. Acad. Sci. USA. 1996. — V.93. — P. 5925−5930.
- Kuiper G.J.M., Carlsson B., Grandien K., Enmark E., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and (3. // Endocrinology 1997. — V. 138. — P. 863−870.
- Weatherill P.J., Wilson A.P.M., Nicholson R.I., et al. Interaction of the antiestrogen ICI 164,384 with the oestrogen receptor. // J. Steroid Biochem. -1988.-V. 30.-P. 263−266.
- VanderKuur J.A., Wiese T. and Brooks S.C. Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex. // Biochemistry. 1993. — V 32. — P. 7002−7008.
- Pilat M.J., Hafner M.S., Krai L.G., Brooks S.C. Differential induction of pS2 and cathepsin D mRNAs by structurally altered estrogens. // Biochemistry. -1993.-V 32.-P. 7009−7015.
- Kohno H., Bocchinfuso W.P., Gandini O., Curtis S.W., and Korach K.S. Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation. // J. Mol. Endocr. 1996. -V. 16.-P. 277−285.
- Schwabe J.W.R., Neuhaus D., Rhodes D. Solution structure of the DNA-binding domain of the oestrogen receptor. // Nature. 1990. — V. 348. — P. 458 461.
- Brzozowski A.M., Pike A.C., Dauter Z., et al. Molecular basis of agonism and antagonism in the oestrogen receptor. // Nature. 1997. — V. 389. — P. 753 758.
- Sato M., Kin J., Short L.L., Slemenda Ch. W., Bryant H.U. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats. // Journal of Pharmacology and Experimental Therapeutics. 1995. — V. 272.-P. 1252−1259.
- Gustafsson J.-A. Raloxifene: magic bullet for heart and bone? // Nature Medicine. 1998. — V. 4. — P. 152−153.
- Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-a. // Nature. 1995. — V. 375. — P. 377−382.
- Renaud J., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-y ligand-binding domain bound to alltrans retinoic acid. // Nature. -1995. V. 378. — P. 681−689.
- Wagner R.L., Apriletti J.W., McGrath M.E., West B.L., Baxter J.D., Fletterick R.J. A structural role for hormone in the thyroid hormone receptor. // Nature. -1995. V. 378. — P. 690−697.
- Anstead G.M., Carlson K.E., and Katzenellenbogen J.A. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. // Steroids. 1997. — V.62. — N 3. — P. 269−303.
- Katzenellenbogen B.S. Antiestrogens: Mechanisms and actions in target cells. // J. Steroid Biochem. Mol. Biol. 1995. — V. 53. — P. 387−393.27. von Angerer E. The Estrogen Receptor as a Target for Rational Drug Design. / New York: Springer, 1995. 239 P.
- Duax W.L. The structure of the crystalline complex estradiol: urea (1:1). // Acta crystallogr. 1972. — V. 28. — P. 1864−1868.
- Palomino E., Heeg M.J., Horwitz J.P., Brooks S.C. Binding, X-ray and NMR studies of the three A-ring isomers of natural estradiol. // J. Steroid Biochem. -1990.-V. 35.-P. 219−229.
- Duax W.L., Griffin J.F., Swenson D.C., Strong P.D., Weisz J. Steroidstructure and function IX. Molecular conformation of catechol estrogens. // J. Steroid Biochem. — 1983. — V. 18. — P. 263−271.
- Wiese T.E., Brooks S.C. Molecular modeling of steroidal estrogens: novel conformations and their role in biological activity. // J. Steroid Biochem. Molec. Biol. 1994. -V. 50. — P. 61−73.
- Ojasoo T., Raynaud J.-P., Dore J.-C. Correspondence factor analysis of steroid libraries. // Steroids. 1995. — V. 60. — P. 458−469.
- Delettre J., Mornon J.P., Lepicard G., Ojasoo T., Raynaud J.-P. Steroid flexibility and receptor specificity. // J. Steroid Biochem. 1980. — V. 13. — P. 4559.
- Fanchenko N.D., Sturchak S.V., Shchedrina R.N., Pivnitsky K.K., Novikov E.A., Ishkov V.L. The specificity of the human estrogen receptor. // Acta Endocr.- 1979.-V. 90.-P. 167−175.
- Chernayaev G.A., Barkova T.I., Egorova V.V., Sorokina I.B., Ananchenko
- Schwartz J.A., Skafar D.F. Ligand-mediated modulation of estrogen receptor conformation by estradiol analogs. // Biochemistry. 1993. — V. 32. — P. 1 010 910 115.
- Duax W.L., Weeks C.M. Molecular basis of estrogenicity: X-ray crystallographic studies. In: McLachlan J.A. (ed). Estrogens in the environment. Elsevier North Holland, New York. P. 11−31.
- Abraham M.H., Duce P.P., Prior D.V., Barratt D.G., Morris J.J., Taylor P.J.
- Hydrogen bonding. Part 9. Solute proton donor and proton acceptor scales for use in drug design. // J. Chem. Soc. Perkin Trans II. 1989. — P. 1355−1375.
- Kollman P.A., Giannini D.D., Duax W.L., Rothenberg S., Wolff M.E. Quantitation of long-range effects in steroids by molecular orbital calculations. // J. Am. Chem. Soc. 1973. — V. 95. — P. 2869−2873.
- Anstead G.M., Kym P.R. Predicted carcinogenicity and structure-estrogen receptor binding affinities of benza.anthracenediols. // Steroids. 1995. — V. 60. -P. 383−394.
- Gabbard R.B., Segaloff A. Structure-activity relationships of estrogens. Effects of 14-dehydrogenation and axial methyl groups at C-7, C-9, and C-11.// Steroids. 1983. — V. 41. — P. 791−804.
- Korenman S.G. Comparative binding affinity of estrogens and its relation to estrogenic potency. // Steroids. 1969. — V. 13. — P. 163−177.
- Katzenellenbogen J.A., Johnson H.J. Jr., Myers H.N. Photoaffinity labels for estrogen binding proteins of rat uterus. // Biochemistry. 1973. — V. 12. — P. 4085−4092.
- Черняев Г. А., Баркова Т. И., Ананченко C.H., Сорокина И. Б., и др. Связывание эстрадиола и его аналогов с цитозольными и ядерными рецепторами матки кролика. // Биоорганическая химия. 1979. — Т. 5, № 6. -С. 869−878.
- Gonzales F.B., Neef G., Eder U., et al. Synthesis and pharmacological evaluation of 8a-estradiol derivatives. // Steroids. 1982. — V. 40. — P. 171−187.
- Kaspar P., Witzel H. Steroid binding to the cytosolic estrogen receptor from rat uterus. Influence of the orientation of substituents in the 17-position of the 8(3-and 8ot-series. // J. Steroid Biochem. 1985. — V. 23. — P. 259−265.
- Clark J.H., Williams M., Upchurch S., et al. Effects of estradiol-17a on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth. // J. Steroid Biochem. 1982. — V. 16. — P. 323−328.
- Palomino E., Heeg M.J., Horwitz J.P., et al. Skeletal conformations and receptor binding of some 9,11-modified estradiols. // J. Steroid Biochem. Molec. Biol. 1994. — V. 50. — P. 75−84.
- Weber H.P., Galantay E. The crystal and molecular structures of an unusual estra-steroids and of its dihydroproduct. // Helv. Chim. Acta. 1972. — V. 55. — N 57. P. 544−553.
- Egorova V.V., Zakharychev A.V., Ananchenko S.N. Structure and reactivity of steroids VI: Long-range effects in a series of A1'3'50^ estratriene compounds. // Tetrahedron. — 1973. — V. 29. — P. 301−307.
- Ali H., Rousseau A.H., Gantchev T.G., van Lier J.E. 2- and 4-Fluorinated1c16a- I. iodoestradiol derivatives: synthesis and effect on estrogen receptor binding and receptor-mediated target tissue uptake. // J. Med. Chem. 1993. — V. 36.-P. 4255−4263.
- Hylarides M.D., Duesler E.N., Mettler F.A., and Leon A.A. Structural comparison of 1-bromo- and 1-fluoroestradiol with d-estradiol. // Acta Cryst. -1988.-V. C44. P. 709−712.
- Wawrzak Z., Duax W.L., Strong P.D., Weisz J. Steroid structure and function. Molecular conformation of 4-hydroxyestradiol and its relation to other catechol estrogens. // J. Steroid Biochem. 1988. — V. 29. — P. 387−392.
- Zeelen F.S., Bergink E.W. In: Raus J., Martens H., LeClercq G., (eds). / Cytotoxic estrogens in hormone receptive tumors. Academic, London. -1980. P. 39−48.
- Yollmer G., Wunsche W., Schutze N., Feit B., et al. Methyl and bromo derivatives of estradiol are agonistic ligands for the estrogen receptor of MCF-7 breast cancer cells. // J. Steroid Biochem. Molec. Biol. 1991. — V. 39. — P. 359 366.
- Heiman D.F., Senderhoff S.G., Katzenellenbogen J.A., Neely R.J. Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. // J. Med. Chem. 1980. — V. 23. — P.994.1002.
- Merriam G.R., Maclusky N.J., Johnson L.A., Naftolin F. 2-Hydroxyestradiol-17a and 4-hydroxyestradiol-17a, catechol estrogens with reduced estrogen receptor binding affinity. // Steroids. 1980. — V. 36. — P. 13−20.
- Qian X-D, Abul-Hajj Y.J. Synthesis and biological activity of 4-methylestradiol. // J. Steroid Biochem. 1990. — V. 35. — P. 745−747.
- Van Aswegen C.H., Purdy R.H., Wittliff J.H. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancer. // J. Steroid Biochem. 1989. — V. 32. — P. 485−492.
- Dandliker W.B., Brawn R.J., Hsu M.L., et al. Investigation of hormone-receptor interactions by means of fluorescent labeling. // Cancer Res. 1978. — V. 38. — P. 4212−4223.
- Muller R.E., Wotiz H.H. Post-coital contraceptive activity and estrogen receptor binding affinity of phenolic steroids. // Endocrinology. 1977. — V. 100. -P. 513−519.
- DaSilva J.N., van Lier J.E. Synthesis and structure-affinity of a series of 7a-undecylestradiol derivatives: a potential vector for therapy and imaging of estrogen-receptor-positive cancers. // J. Med. Chem. 1990. — V. 33. — P. 430−434.
- VanBrocklin H.F., Liu A., Welch M.J., et al. The synthesis of 7a-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents. // Steroids. 1994. — V. 59. — P. 34−45.
- Ali H., and van Lier J.E. Synthesis and receptor binding affinity of 7a- and 17a-substituted 2- and 4-chloroestradiol derivatives. // J. Chem. Soc. Perkin Trans. I. 1991. — P. 2485−2491.
- Neef G., Cleve A., Depke G., and Eckle E. Synthesis and spectroscopic peculiarities of 1 l (3-aryl-estra-4,8(14), 9-trienes and 1 l (3-aryl-estra-5(10), 6,8-trienes. // Tetrahedron Let. 1997. — V. 38. — P. 3897−3900.
- Pomper M.G., Van Brocklin Z.H., Thieme A., et al. 1 l (3-Methoxy, lip-ethyl, and 17a-ethynyl-substituted 16a-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity. // J. Med. Chem. 1990. — V. 33. -P. 3143−3155.
- Bull J. R., Hoadley C., Mountford P.G., and Steer L.M. Synthesis of 14,17-propano analogues of estradiol. // J. Chem. Soc. Perkin Trans. I. 1997. — P. 1179−1192.
- Siemann H.J., Droescher P., Undeutsch B., and Schwarz S. A novel synthesis of 14a, 15a-methylene estradiol (J 824). // Steroids. 1995. — V. 60. — P. 308 315.
- Bohl M., Schubert G., Koch M., Reck G., et al. Quantitative structure-activity relationships of estrogenic steroids substituted at CI4, CI 5. // J. Steroid Biochem. 1987.-V. 26.-P. 589−597.
- Fevig T.L., Mao M.K., Katzenellenbogen J.A. Estrogen receptor binding tolerance of 16a-substituted estradiol derivatives. // Steroids. V. 51. — P. 471 497.
- Salman M., Reddy B.R., Delgado P., Stotter P.L., et al. 17a-substituted analogs of estradiol for the development of fluorescent estrogen receptor ligands. //Steroids. 1991.-V. 56.-P. 375−387.
- Johns W.F. Synthesis of 18,19-dinor steroids. // J. Am. Chem. Soc. 1958. -V. 80, N5.-P. 6456−6457.
- Jensen E.V., Jecobsen H.I. Fate of steroidal estrogens in target tissue. In: «Biological activities of steroids in relation to cancer» (Ed. by G. Pincus, E.P. Volmer). 1960. — P. 161−178.
- Farhat M.Y., Abi-Younes S., Ramwell P.W. Non-genomic effects of estrogen and the vessel wall. // Biochem. Pharmacol. 1996. — V. 51. — P. 571−576.
- Farhat M.Y., Lavigne M.C., and Ramwell P.W. The vascular protective effects of estrogen. // The FASEB Journal. 1996. — V.10. — P.615−624.
- McDonnell D.P., and Norris J.D. Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone. // Osteoporosis Int. 1997. — V. 1. (Suppl.) — P. S29-S34.
- Smith D.F., Toft D.O. Steroid receptors and their associated proteins. // Mol. Endocr. 1993. — V. 7. — P. 4−11.
- Denis M, Poellinger L, Wikstron A, Gustafsson J. A. Requirement of hormone for thermal conversion of the glucocorticoid receptor to a DNA-binding state. // Nature. 1988. — V. 333. — P. 686−688.
- Katzenellenbogen B.S., Bhardwaj B., Fang H., Ince B.A. et al. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems. // J. Steroid Biochem. Molec. Biol. 1993. — V. 47. — P. 39−48.
- Beekman J.M., Allan G.F., Tsai S.Y., et al. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. // Mol. Endocr. 1993. — V. 7. — P. 1266−1274.
- McDonnell D.P., Nawaz Z., O’Malley B.W. In situ distinction between steroid receptor binding and transactivation at a target gene. // Mol. Cell Biol.1991.-V. 11.-P. 4350−4355.
- Kumar V., Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. // Cell. 1988. — V. 55. — P. 145−156.
- Khursheed P. D., Garabedian M.J., Fortin M.G., Lindquist S., Yamamoto K.R. Reduced levels of hsp90 compromise steroid receptor action in vivo. II Nature. 1990. — V. 348. — P. 166−168.
- Bagchi M.K., Tsai S.Y., Tsai M-J, O Malley B.W. Progesterone Enhances Target Gene Transcription by Receptor Free of Heat Shock Proteins hsp90, hsp56, and hsp70. //Mol. Cell. Biol. 1991. — V. 11.-P. 4998−5004.
- Bagchi M.K., Tsai S.Y., Tsai M-J, O Malley B.W. Identification of a functional intermediate in receptor activation in progesterone-dependent cell-free transcription. //Nature. 1990. — V. 345. — P. 547−550.
- Weigel N.L. Steroid hormone receptors and their regulation by phosphorylation. // Biochem. J. 1996. — V. 319. — P. 657−667.
- Chetrite G., and Pasqualini J.R. Biological responses of ICI 164,384 and anti-estrogens in vaginal and uterine cells of fetal guinea pig in culture. // Acta Endocrinologica. 1991. — V. 125. — P. 401−408.
- Grese T.A. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene. // J. Med. Chem. 1997. — V. 40. — P. 146−167.
- Draper M.W. A controlled trial of raloxifene (LY139481) HC1: impact on bone turnover and serum lipid profile in healthy postmenopausal women. //J. Bone Miner. Res. 1996. — V. 11. — P. 835−842.
- McDonnell D.P., Clemm D.L., Herman T., et al. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. // Mol.
- Endocr. 1995. — V. 9. — P. 659−669.
- Meyer M.E., Pornon A. J., Bocquel M.T., et al. Agonist and antagonist properties of RU486 on the functions of the human progesterone receptor. // EMBO J. 1990. — V. 9. — P. 3923−3932.
- Webb P., Lopez G.N., Uht R.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogenlike effects of antiestrogens. // Mol. Endocr. 1995. — V. 9. — P. 443−456.
- Gibson M.K., Nemmers L.A., Beckman W.C.J., et al. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. // Endocrinol. -1991. V. 129. — P. 2000−2010.
- Mahfoudi A., Roulet E., Dauvois S., et al. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.// Proc. Natl. Acad. Sci. USA. 1995. — V. 92. — P. 4206−4210.
- Wrenn C.K., Katzenellenbogen B.S. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. // J. Biol. Chem. 1993. — V. 268. — P. 24 089−24 098.
- Norris J., Fan D., Aleman C., Marks J.R., et al. Identification of a new subclass of alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. // J. Biol. Chem. 1995. — V. 270. — P. 22 777−22 782.
- Danielian P. S., White R., Lees J.A., and Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. // EMBO J. 1992. — V. 11. — P. 1025−1033.
- Beato M., and Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. // Endocr. Rev. 1996. — V. 17. — P. 587 609.
- Mclnerney E.M., Tsai M.-J., O’Malley B.W., and Katzenellenbogen B.S. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. // Proc. Natl. Acad. Sci. USA. 1996. — V. 93. — P. 1 006 910 073.
- Mclnerney E.M., Katzenellenbogen B.S. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcriptional activation. // J. Biol. Chem. 1996. — V. 271. -P. 24 172−24 178.
- Cavailles V., Dauvois S., Danielian P. S., et al Interaction of proteins with transcriptionally active estrogen receptors. // Proc. Natl. Acad. Sci. USA.- 1994. -V. 91. P. 10 009−10 013.
- Pakdel F., Reese J.C., and Katzenellenbogen B.S. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.// Mol.
- Endocrinol. 1993. — V. 7. — P. 1408−1417.
- Henttu P.M.A., Kalkhoven E., and Parker M.G. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. // Mol. Cell. Biol. 1997. — V. 17. -P. 1832−1839.
- Grady D., Rubin С., Pettiti D. et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. // Ann. Intern. Med. 1992. — V. 117. — P. 1016−1037.
- Сметник В.П., Чернуха Г. Е., Кузнецов С. Ю. Особенности липидного состава сыворотки крови у женщин с преждевременным выключением функции яичников. // Сов. мед. 1991. — № 6. — С. 17−20.
- Клименченко Н.И. Влияние заместительной гормональной терапии на сердечно-сосудистую систему у женщин в постменопаузе. // Акуш. и гинекол. 1995. — N 3. — С. 10−14.
- Болезни сердца и сосудов. / Под ред. Е. И. Чазова. М.: Наука, 1992. -Т. 2. — С. 136−176.
- Нагорнев В.А. Современные аспекты патогенеза атеросклероза. // Арх. пат. 1991. — Т. 53, N 9. — С. 13−21.
- Stampfer М. J., Colditz С. A., and Willett W. С. Menopause and heart disease: a review. Ann. N.Y. Acad. Sci. // Annu. Rev. Biochem. 1989. — V. 592. — P. 193−203.
- Sullivan J. Hormone replacement therapy and cardiovascular disease: the human model. // Brit. J. Obstet. Gynecol. 1996. — V. 103. — P. 59−67.
- Godsland I., Wynn V., Crook D., Miller N. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. // Am. Heart J. 1987. -V. 114. — P. 1487−1503.
- Lobo R. Cardiovascular implications of estrogen replacement therapy. // Obstet. Gynecol. 1990. — V. 75 (Suppl.). — P. 18S-25S.
- Harlap S. The benefits and risks of hormone replacement therapy an epidemiologic overview. // Am. J. Obstet. Gynecol. — 1992. — V. 166. — P. 19 861 992.
- Те Velde E., Van Leusden H. Hormonal treatment for the climacteric: alleviation of symptoms and prevention of postmenopausal disease. // Lancet. -1994. -V. 343. P. 654−658.
- Li J.J., Li S.A., Oberley T.D., Parsons J.A. Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation. // Cancer Res. 1995. — V. 55. — P. 43 474 351.
- Шавва А.Г. Синтез аналогов стероидных эстрогенов с избирательным биологическим действием. / Диссертация на соискание ученой степени доктора химических наук. JL, ЛГУ, 1987. — 365 с.
- Peters R.H., Crowe D.F., Avery М.А., Chong W.K.M., Tanabe M. Analogues of (triethylsilyl)ethynyl.estradiol as potential antifertility agents. // J. Med.Chem. 1988. — V. 31. — P. 572−576.
- Merriam G.R., Maclusky N.J., Picard M.K., Naftolin F. Comparative properties of the catechol estrogens. I: Methylation by catechol-o-methyltransferase and binding to cytosol estrogen receptors. // Steroids. 1980. -V. 36. — P. 2589−2590.
- Pat. 1 108 664 Brit., cl. C07c. 13-Alkyl-l, 3,5(10)-trienes. / Smith H., Hughes G.A., 1968.
- AboulWafa O.M., Omar A.-Mohsen M.E. and Mohy El-Din M.M. Synthesis and evaluation for uterotrophic and antiimplantation activities of 2-substituted estradiol derivatives. // Steroids. 1992. — V. 57, N 4. — P. 199−204.
- Ismail K.A. and El-Medany A. Synthesis and uterotrophic activity of 2-substituted estradiol and ring A fused pyranone and furanone derivatives. // Alex. J. Pharm. Sci. -1994/95. V. 8, N 2. — P. 95−99.
- Pat. 1 069 845 Brit., cl. C07c. Steroids. / Smith H., Hughes G.A., 1965.
- Pat. 3 407 217 U.S.A., cl. C07c. Substituted 8-isogonanes. / Hughes G.A., Smith H, 1968.
- Pat. 1 069 845 Brit., cl. C07d. 8-Iso-6-oxasteroids and D-homo-8-iso-6-oxasteroids. / Hughes G.A., Smith H., 1967.
- Pat. 1 069 846 Brit., cl. C07d. 6-Oxagonatrienes and D-homo-6-oxagonatrienes. / Hughes G.A., Smith H., 1967.
- Каменева И.Ю., Шавва А. Г., Лозовский B.T., Рыженков В. Е. Гиполипидемическое действие 6-окса-0-гомо-8-изоэстрона и его метилового эфира. // Бюлл. эксп. биол. мед. 1994. — N 3. — С. 262−264.
- Kirchhoff J., Wang X., Chraf R., et. al. Interaction of methylestrogen with cytoplasmic and nuclear estrogen receptor in rat pituitary gland, hypothalamus and uterus. // Brain Res. 1984. — V. 294. — N 2. — P. 354−358.
- Шавва А.Г., Бороноева T.P., Злобина И. В. и др. Исследование взаимодействия гормон-рецептор в ряду 8-изоаналогов стероидных эстрогенов. // Вестник ЛГУ. 1981. — N 16, вып. 3. — С. 117−119.
- Nambara Т., Honma S., Akiyama S. Studies on steroid conjugates. III. New syntheses of 2-methoxyestrogens. // Chem. Pharm. Bull. 1970. — V. 18, N 3. -P. 474−480.
- Crabbe P., Maldonado L.A., Sanches I. Synthesis of new heterocyclic derivatives of estradiol. // Tetrahedron. 1971. — V. 27. — P. 711−725.
- Шавва А.Г., Елисеев И. И., Бурова Е. Б. и др. Региоселективное ацилироваиие аналогов стероидных эстрогенов по реакции Фриделя-Крафтса. // ЖОрХ. 1986. — Вып. 2. — С. 442−443.
- Xie R. G., Deng L.S., Gu Н. G., Fan Y.M., Zao H.M. A synthetic route to 2-hydroxyl steroidal estrogens via acetylation and Dakin oxidation. // Steroids. -1982.-V. 40, N4.-P. 389−392.
- Pat. 535 595 A2 Europ., cl. C07J. Manufacture and use of novel glycosides of catechol estrogens. /Takehiko S., Sadaaki K., Naoko I., et al. 1992.
- Ананченко C.H., Торгов И. В. Новый путь синтеза стероидных соединений. Синтез D-гомоэквиленина и D-гомоизоэквиленина. // ДАН СССР. 1959. — Т. 127, N 3. — С. 553−556.
- Blickenstaff R.T., Ghosh А.С., Wolf G.C. Total synthesis of steroids. / New York and London: Academic Press, 1974.
- Торгов И.В. Синтез стероидных гормонов. // Изв. АН СССР. Сер. хим. -1982. -N 2. С. 299−317.
- Торгов И.В. Химия стероидов. // Биоорг. химия. 1984. — Т. 10. — N 8. -С. 1059−1077.
- Kuo С.Н., Taub D., Wendler N.L. A synthesis of estrone via novel intermediates. // Chem. Ind. 1966. — N 31. — P. 1340−1341.
- Kuo C.H., Taub D., Wendler N.L. A synthesis of estrone via novel intermediates. Mechanism of the coupling reaction of a vinyl carbinols with a |3-diketones. // J. Org. Chem. 1968. — V. 33. — N 8. — P. 3126−3132.
- Гриненко E.B. Синтез биологически активных веществ на основе стероидных эстрогенов. / Диссертация на соискание ученой степени кандидата химических наук. Л., ЛГУ, 1989. — 149 с.
- Dann О., Hagedorn K.W., Hofmann Н. Chromane, XYIII: Synthese von 7a-methyl-6-oxa-ostron. // Chem. Ber. 1971. — Bd. 104. — N 10. — S. 3313−3328.
- Bischofberger К., Bull J.R. 14-Methyl steroids. Part 3. Synthesis of (±)-14a-methyl-9(3-estradiol and related 14a-methyl-19-norsteroids. // Tetrahedron. -1985. V. 41. — N 2. — P. 365−374.
- Cao Zh., Liehr J.G. Total synthesis of 3-hydroxy-6-oxaestra-l, 3,5(10)-trien-17-one. // J. Chem. Soc. Perkin Trans. 1. 1996. — P. 841−844.
- Лиманов B.E., Ананченко C.H., Торгов И. В. Синтез d, l-8-H30-D-r0M0-эстрона и соответствующего эстрадиола. // Изв. АН СССР. Сер. хим. 1964. -С. 1814−1819.
- Бохман Я.В., Прянишников В. А., Чепик О. Ф. Комплексное лечение при гиперпластических процессах и раке эндометрия. / М.: Медицина, 1979. 272 с.
- Ищенко И.В., Гриненко Е. В., Елисеев И. И., Шавва А. Г. Синтез стероидных эстрогенов, содержащих метильную группу при С4. // ЖОрХ. -1987.-Вып. 6.-С. 1337−1339.
- Xie R., Chen Q., Xie J., Zhao H. A new efficient synthetic method for 2-and 4-hydroxy-17a-ethynylestradiol. // Steroids. 1990. — V. 55. — N 11. — P. 488 490.
- Pert D. J., Ridley D.D. Formylation of oestrogens. // Aust. J. Chem. 1989. -V. 42.-P. 405−419.
- Ахрем A.A., Титов Ю. А. Полный синтез стероидов. М.: Наука, 1967. -200 с.
- Wittstruck Т.A., Williams K.I.H. Carbon-13 magnetic resonance of steroids. Estra-1,3,5(10)-trienes. // J. Org. Chem. 1973. — V. 38. — N 8. — P. 1542−1548.
- Douglas G.H., Buzby G. C., Walk R.C., Smith H. Totallysynthetic steroid hormones (±)-6a- and 6(3-methylestra-l, 3,5(10)-trienes and related compounds. // Tetrahedron. 1966. — V. 22. — P. 1019−1025.
- Wender P.A. and Smith Т.Е. Transition metal-catalyzed intramolecular 4+2. cycloadditions: initial studies on stereochemistry and on steroid and vitamin D analog syntheses. // J. Org. Chem. 1995. — V. 60. — P. 2962−2963.
- Леонов B.H., Ананченко C.H., Торгов И. В. Новый путь синтеза стероидных соединений. Полный синтез dl-8-изоэстрона. // Докл. АН СССР. Сер. хим. 1961. — Т. 138, N 2. — С. 384−386.
- Kursanov D.N., Parnes Z.N., Bassova G.I., Zoim N.M., Zdanovich V.I. Ionic hydrogenation of the ethylene bond and the double bond of the carbonyl group. // Tetrahedron. 1967. — V. 23, N 5. — P. 2235−2242.
- Kursanov D.N., Parnes Z.N., Loim N.M. Applications of ionic hydrogenation to organic synthesis. // Synthesis. 1974. — P. 633−651.
- Серебрякова Т.А., Захарычев A.B., Ананченко C.H., Торгов И. В. Ионное гидрирование производных1. Д8(9), 14(15)-бисдегидроэстрановых систем. // Изв. АН СССР. Сер. хим. 1974. — N 3. — С. 742−743.
- Васияров Г. Г., Калинкин М. И., Ананченко С. Н., и др. Каталитическое ионное гидрирование 8(9), 14(15)-бисдегидроэстрона, 8(9), 14(15)-бисдегидро-О-гомоэстрона и их производных. // Изв. АН СССР. Сер. хим. -1981.-N9.-С. 2144−2146.
- Серебрякова Т.А., Парнес З. Н., Захарычев А. В., Ананченко С. Н., Торгов И. В. Стереоспецифическое восстановление стирольной двойной связи в D-гомостероидах. // Изв. АН СССР. Сер. хим. -1969. N 3. — С. 725.
- Серебрякова Т.А., Чигирь Р. Н., Захарычев А. В., Ананченко С. Н., Торгов И. В. Стереонаправленный метод получения эстрановых соединений природной конфигурации. // Изв. АН СССР. Сер. хим. -1973. N 8. — С. 1917.
- В. Ramesh Babu, D.V. Ramana, and S.R. Ramadas. Studies of novel pentacyclic heterocyclic steroids: part XXI. Total synthesis of racemic benz3,4.-6-oxaestra-l, 3,5(10), 8-tetraen-17(3-ol. // Steroids. 1990. — V. 55. — P. 101−104.
- Simpkins J.W., Green P. S., Gridley K.E., et al. // Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer’s disease. // The Amer. J. of Medicine. 1997. — V. 103.-P. 19S-25S.
- Кошоев K.K., Ананченко C.H., Торгов И. В. Варианты полного синтеза d, l-3CTpoHa на основе 1-винил-6-метокситетралола и 2-метилциклогександиона-1,3. //ХПС. 1965. — С. 172−180.
- Елисеев H.H., Жуковский Е. А., Шавва А. Г. Синтез рацемического 7а-метил-8-изоэстрадиола. // Вестник СПбГУ. 1992. — Серия 4, вып. 2. — С. 6771.
- Pat. 1 108 664 Brit., cl. C07c. 13-Alkyl-l, 3,5(10)-triens. / Smith Н., Hughes G.A., 1968.
- Платонова A.B., Ананченко С. Н., Торгов И. В. Полный синтез метиловых эфиров d, l-8-H303CTp0Ha, d, l-9-H303CTp0Ha и d, l-9,14-H303CTp0Ha. // Изв. АН СССР. Сер. хим. 1974. — N 7. — С. 1581−1586.
- Pat. 3 546 292 U.S.A., cl. C07c. B-Norestratrienes having blood cholesterol-lowering activity. / Georgian V., Preiffer F.R., 1971.
- Касымов C.K., Захарычев A.B., Ананченко С. Н., Торгов И. В. Химические превращения 3-метиловых эфиров 14a-OKCH-9ß--D-гомоэстрона. // Изв. АН СССР. Сер. хим. 1972. — N 11. — С. 26−25−2627.
- Аль-Сафар Н., Захарычев A.B., Ананченко С. Н., Торгов И. В. Синтез некоторых 16,16-диметил-0-гомо-стероидов. // Изв. АН СССР. Сер. хим. -1968.-N10.-С. 2326−2332.
- Groen M.B. and Zeelen F.J. Biomimetic total synthesis of steroids YIII.
- Stereospecific synthesis of B-homo-19-nor-steroids. // Recueil, J. R. Neth.Chem.Soc. 1984. — V. 103, N 5. — P. 169−173.
- Cambie R.C., Taylor M.J., Rutledge P. S., at el. Dynamic NMR analysis of conformational isomerism in diterpenoid carboxamide. // Magn. Reson. in Chem. 1996. — V. 34, N 5. — P. 360−364.
- Nagawa Y., Honda K. and Nakanishi H. Dynamic Nuclear Magnetic Resonance study of rotational isomerism in naphthalenes peri substituted with triazole rings. // Magn. Reson. in Chem. 1996. — V. 34, N 1. — P. 78−82.
- Shanan-Atidi H. and Bar-Eli K.H. A convenient method for obtaining free energies of activation by the coalescence temperature of unequal doublet. // J. Phys. Chem. 1970. — V. 74. — N 4. — P. 961−963.
- Weiner S.J., Kollman P.A. A new force field for molecular mechanical simulation of nucleic acids and proteins. // J. Am. Chem. Soc. 1984. — V. 106. -P. 765−784.
- Dewar M.J.S., Zoebisch E.G., Healy E.F., Stewart J.J.P. AMI: a new general purpose quantum mechanical molecular model. // J. Am. Chem. Soc. -1985.-V. 107.-P. 3902−3909.
- Neeman M., Kartha G., Go K., et al. Modified steroid hormones. 7. 4-Fluoro-17P-estradiol: carbon-13 nuclear magnetic resonance, crystal and molecular structure, and biological activity. // J. Med. Chem. 1983. — V. 26. -P. 465−469.
- Palomino Е., Heeg M.J., Pilat M.J., et al. Crystal structure, receptor binding, and gene regulation of 2- and 4-nitroestradiols. // Steroids. -V. 61, N11.-P. 670−676.
- Precigoux G., Marsau О., Leroy F., and Busetta В. 17?-Hydroxymethyl-1,3,5(10)-estratrien-3-ol monohydrate. // Acta Cryst. 1980. — V. B36. — P. 749 751.
- Китайгородский А.И. Молекулярные кристаллы. / М.: Наука, 1975. -298 С.
- Шамовский И.Л., Баренбойм Г. М., Овчинников A.A. Теоретическое исследование связи между структурой и активностью кардиотонических стероидов. // Биоорган, химия. 1983. — Т.9, N 8. — С.1112−1127.
- Duax W.L., Norton D.A. // Atlas of steroid structure. N.Y.: Plenum Press, 1975. V.l. — P. 572.
- Овсецина Т.И., Малахова Л. Ф., Чернобурова Е. И. и др. Молекулярная и кристаллическая структура ЗР-ацетоксипрегн-5-ен-20-она. // Кристаллогр. 1998. — Т. 43, N 2. — С. 258−261.
- Овсецина Т.И., Малахова Л. Ф., Чернобурова Е. И. и др. Молекулярная и кристаллическая структура 3 ?-ацетокси-17Р-гидрокси-17а-этинил-5 ß-, 6ß--эпоксиандростана С23Н32О4. // Кристаллогр. 1998. — Т. 43, N 2. — С. 254 257.
- Thomas G.J., Nathan A.H. 6-Methoxy-l-tetralone. // J. Am. Chem. Soc. -1948.-V. 70.-P. 331−334.
- Ananchenko S.N., Limanov V.Yu., Leonov V.N., et al. Synthesis of derivatives of oestrane and 19-norsteroids from 6-methoxytetralone and 6-hydroxytetralone. // Tetrahedron. 1962. — V. 18. — P. 1355−1367.
- Крылова Е.Б. Синтез аналогов 1,3,5(10)-эстратриена для исследования белков, связывающих эстрогены. / Диссертация на соискание ученой степени кандидата химических наук. Л., ЛГУ, 1978. — 161 с.
- Коган Л.М., Гулая В. Е., Лакум Б., Торгов И. В. Получение метилового эфира d, l-8,14-ceкo-D-гoмo-Л1'3'5(10)'9(П)-эcтpaтepaeндиoл-3,17aa-oнa-14 и его использование в синтезе d, l-D-r0M03CTp0Ha. // Изв. АН СССР. Сер. хим. -1970- С. 1356.
- Ржезников В.М., Ананченко С. Н., Торгов И. В. Восстановление некоторых D-гомостероидов с ароматическим кольцом, А некоторыми щелочными металлами в условиях реакции Берча. // ХПС. 1965. — С. 90 100.